2009Sichuan Mental HealthRequires access

A controlled study on aripiprazole and risperidone in the treatment of schizophrenic outpatients

Shu Fe

Open publisher page 0 citations

Abstract

Objective To research the therapeutic and side effects of aripiprazole in the treatment of schizophrenic patients.Methods Thirty schizophrenic patients were treated with risperidone as the controlled group.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the adverse events were determined by the treatment emergent symptoms scale(TESS).Results The efficacy rate of risperidone was 83.3%,in which 53.3% were improved markedly.The efficacy rate of aripiprazole was 86.7%,in which 73.3% were improved markedly.Conclusion It is suggested that both drugs are effective exactly in the treatment of schizophrenic patients.Aripiprazole appears to be more effective in improving psychiatric symptoms

About this research paper

What this paper is about

Objective To research the therapeutic and side effects of aripiprazole in the treatment of schizophrenic patients.Methods Thirty schizophrenic patients were treated with risperidone as the controlled group.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the adverse events were determined by the treatment emergent symptoms scale(TESS).Results The efficacy rate of risperidone was 83.3%,in which 53.3% were improved markedly.The efficacy rate of aripiprazole was 86.7%,in which 73.3% were improved markedly.Conclusion It is suggested that both drugs are effective exactly in the treatment of schizophrenic patients.Aripiprazole appears to be more effective in improving psychiatric symptoms

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To research the therapeutic and side effects of aripiprazole in the treatment of schizophrenic patients.Methods Thirty schizophrenic patients were treated with risperidone as the controlled group.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the adverse events were determined by the treatment emergent symptoms scale(TESS).Results The efficacy rate of risperidone was 83.3%,in which 53.3% were improved markedly.The efficacy rate of aripiprazole was 86.7%,in which 73.3% were improved markedly.Conclusion It is suggested that both drugs are effective exactly in the treatment of schizophrenic patients.Aripiprazole appears to be more effective in improving psychiatric symptoms

Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Negative symptom, Psychology, Adverse effect, Positive and Negative Syndrome Scale, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
A controlled study on aripiprazole and risperidone in the treatment of schizophrenic outpatients — Research Paper | ScholarLens